Lang James Paul

CIK 00017030903 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001703090

Recent Transactions

50 trades

Award
OptimizeRx Corp$OPRX
Common Stock
2026-06-09+34,517→ 433,837 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-05-05+6,040→ 6,040 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-05-05+3,796→ 4,685 total
Award
BIOVIE INC.$BIVI
Stock Option (right to buy)
2026-01-05+90,000→ 90,000 total
Award
BIOVIE INC.$BIVI
Stock Option (right to buy)
2026-01-05+330,500→ 330,500 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-01-02+889→ 889 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-01-02+1,342→ 1,342 total
Award
OptimizeRx Corp$OPRX
Common Stock
2025-06-11+9,868→ 399,320 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2025-03-14$7.60/sh+321,408→ 389,452 total
Award
BIOVIE INC.$BIVI
Stock Option (right to buy)
2024-12-20+22,690→ 22,690 total
Award
BIOVIE INC.$BIVI
Stock Option (right to buy)
2024-11-20+61,600→ 61,600 total
Award
OptimizeRx Corp$OPRX
Common Stock
2024-06-07+13,286→ 68,044 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2024-06-05+10,061→ 54,758 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2024-06-05−10,061→ 0 total
Award
BIOVIE INC.$BIVI
Stock Option (right to buy)
2023-11-09+93,500→ 93,500 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2023-06-07−4,637→ 0 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2023-06-07+10,061→ 10,061 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2023-06-07+4,637→ 44,697 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2023-03-30−657→ 657 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2023-03-30+657→ 40,060 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2022-12-30+409→ 39,403 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2022-12-30−409→ 0 total
Award
BIOVIE INC.$BIVI
COMMON STOCK
2022-11-23+43,578→ 68,622 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2022-09-29−334→ 0 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2022-09-29+334→ 38,994 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2022-08-19$16.45/sh+6,000→ 38,660 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2022-06-09+4,637→ 4,637 total
Award
BIOVIE INC.$BIVI
Stock Option (right to buy)
2022-04-05+127,900→ 127,900 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2022-03-30+657→ 657 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2021-12-30+409→ 743 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2021-09-29+334→ 334 total
Award
OptimizeRx Corp$OPRX
Common Stock
2021-06-30+407→ 32,660 total
Award
OptimizeRx Corp$OPRX
Common Stock
2021-03-31+539→ 32,253 total
Award
OptimizeRx Corp$OPRX
Common Stock
2020-12-31+802→ 31,714 total
Award
BIOVIE INC.$BIVI
options
2020-12-18$13.91/sh+99,000→ 120,988 total
Award
OptimizeRx Corp$OPRX
Common Stock
2020-09-30+1,183→ 30,912 total
Award
OptimizeRx Corp$OPRX
Common Stock
2020-06-30+1,937→ 29,729 total
Award
OptimizeRx Corp$OPRX
Common Stock
2020-03-30+2,784→ 27,792 total
Award
BIOVIE INC.$BIVI
options
2020-01-19$2.80/sh+800→ 21,988 total
Award
OptimizeRx Corp$OPRX
Common Stock
2020-01-03+2,084→ 25,008 total
Award
BIOVIE INC.$BIVI
Common Stock
2020-01-02$3.50/sh+1,600→ 25,044 total
Award
OptimizeRx Corp$OPRX
Common Stock
2019-09-30+2,084→ 22,924 total
Award
OptimizeRx Corp$OPRX
Common Stock
2019-03-29+2,084→ 14,585 total
Award
BIOVIE INC.$BIVI
options
2019-01-19$3.75/sh+800→ 21,188 total
Award
BIOVIE INC.$BIVI
Common Stock
2019-01-02$0.04/sh+200,000→ 450,000 total
Award
OptimizeRx Corp$OPRX
Common Stock
2018-10-08+2,084→ 12,501 total
Award
BIOVIE INC.$BIVI
Preferred Stock
2018-07-03$1.50/sh+20,000→ 20,000 total
Award
BIOVIE INC.$BIVI
Warrants
2018-07-02$0.02/sh+2,000,000→ 2,548,485 total
Award
OptimizeRx Corp$OPRX
Common Stock
2018-06-29+2,084→ 10,417 total
Award
BIOVIE INC.$BIVI
options
2018-01-19$0.10/sh+100,000→ 548,485 total

Companies

Recent Filings

Address

C/O OPTIMIZERX CORPORATION 260 CHARLES STREET, SUITE 302

WALTHAM, MA, 02453

View on SEC.gov